Hamamatsu With Revenue Growth
Net sales are ?1.2b (up by 1.1% from last year, +?12.5m). Sales in the industrial field declined significantly due to U.S.-China trade conflict and downhold of capital investment, but this was covered by medical-bio field and reached a record high. Operating income is ?212.5m (down by 6.8% from last year, -?15m). Caused by increase of cost rate, and selling, general, administrative expenses. Net income is ?166.5m (down by 6.1% year-on-year, -?10.8m).